相关实验视频
Updated: Jun 20, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
人类微生物群和益生菌对白血病的影响的进展
Yi Zhang1, Xiaotong Zhao1, Jingxian Zhang1
1Henan Key Laboratory of Children's Genetics and Metabolic Diseases, School of Pharmaceutical Sciences, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou University, Zhengzhou, China.
肠道微生物群,体内微生物的生态系统,与白血病的发展有关. 益生菌可以通过平衡肠道细菌来帮助治疗白血病,尽管需要更多的研究.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 人的肠道微生物群是一个复杂的生态系统,对宿主环境相互作用和生理功能至关重要.
- 新兴研究强调了肠道微生物群失生症与包括白血病在内的各种癌症的致病关系.
- 白血病是一种常见的儿童癌症,涉及不受控制的血细胞增殖,其机制涉及肠道微生物群失衡.
研究的目的:
- 审查关于肠道微生物群,益生菌和白血病进展之间的关系的当前研究.
- 探索益生菌在调节肠道微生物组中对白血病治疗的潜在作用.
- 识别知识缺口,并建议未来的研究方向,包括使用斑马鱼模型.
主要方法:
- 关于肠道微生物群,益生菌和白血病现有研究的文献综述.
- 对将微生物失衡与白血病病理学联系起来的研究分析.
- 探索肠道健康和癌症中的益生菌机制.
主要成果:
- 肠道微生物群的不平衡与白血病的发展和进展有关.
- 益生菌显示出调节肠道微生物群的潜力,并可能有助于治疗白血病.
- 需要进一步的研究来阐明特定的微生物作用和治疗应用.
结论:
- 肠道微生物群在白血病的发病过程中起着重要作用.
- 益生菌为白血病患者提供了潜在的治疗途径.
- 未来的研究,特别是使用斑马鱼模型,对于理解精确的相互作用和改善临床结果至关重要.
更多相关视频
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...